Headache & Migraine Disease Working Group
The Headache and Migraine Disease Working Group is a network of policy-minded health care providers who advocate for patient-centered care.
By participating in advocacy initiatives and the development of educational resources, working group members ensure that the clinician’s perspective informs policy discussions that impact health care for people living with headache disorders or migraine disease.
To learn more, or to join AfPA’s Headache and Migraine Disease Working Group, please email info@allianceforpatientaccess.org.
Resources
White Papers & Policy Briefs
- Left Out: How Health Plan Exclusion Lists Undermine Migraine Treatment
Alliance for Patient Access, December 2022 - 2022 Working Group Summary
Alliance for Patient Access, October 2022 - Patient-Centered Care: A Position Statement
Alliance for Patient Access, August 2022 - Prior Authorization & Treatment Delays
The Headache & Migraine Policy Forum, Movement Disorders Policy Coalition, Alliance for Patient Access, February 2021 - Telemedicine: A Position Statement
Alliance for Patient Access, July 2020 - In Conversation: A Physician Discusses COVID-19 and Migraine Treatment
Alliance for Patient Access, May 2020 - High Out-of-Pocket Costs: A Position Statement
Alliance for Patient Access, July 2019 - Non-Medical Switching: A Position Statement
Alliance for Patient Access, July 2019 - Treatment Challenges for People with Headache and Migraine Disease
Institute for Patient Access, June 2019 - Co-Pay Accumulator Programs: A Position Statement
Alliance for Patient Access, May 2019 - Prior Authorization: A Position Statement
Alliance for Patient Access, April 2019 - A Study of the Qualitative Impact of Non-Medical Switching | Abstract
Alliance for Patient Access, February 2019 - Step Therapy: A Position Statement
Alliance for Patient Access, January 2019 - Botulinum Neurotoxins and Non-Medical Switching
Institute for Patient Access, December 2018 - ICER Case Study: Migraine
Institute for Patient Access, April 2018
Videos
- The Pain of Waiting for Migraine Medication
Alliance for Patient Access, February 2021 - Why Health Care Providers Should Care About ICER
Institute for Patient Access, November 2019 - Maureen Moriarty, DNP, on Barriers to Migraine Treatment
Alliance for Patient Access, November 2019 - Heather McCoy, DrNP, on Barriers to Migraine Treatment
Alliance for Patient Access, November 2019 - Christopher Gottschalk, MD, on Barriers to Migraine Treatment
Alliance for Patient Access, November 2019 - My Migraine Patients’ Combination Therapy Battle
Alliance for Patient Access, September 2019 - Non-Medical Switching Hurts Patients
Alliance for Patient Access, March 2019 - Non-Medical Switching of Neurotoxins
Alliance for Patient Access, February 2019
Infographics
- Migraine Patients & Disparities in Care
Alliance for Patient Access, June 2022 - Headache and Migraine Disease Can Be Severe
Alliance for Patient Access, April 2022 - Headache Disorders & Non-Medical Switching
Alliance for Patient Access, September 2021 - Are Insurers Out of Step on Migraine Disease?
Alliance for Patient Access, June 2021 - When Insurers Limit Migraine Patients
Alliance for Patient Access, February 2021 - How Excessive Prior Authorization Hurts Patients
Alliance for Patient Access, December 2020 - Migraine Disease is a Spectrum
The Headache and Migraine Policy Forum, October 2019 - Women, Migraine Disease & the Workplace
The Headache and Migraine Policy Forum, June 2019 - Why Can’t Migraine Patients Access Combination Therapy?
The Headache and Migraine Policy Forum, May 2019 - How Non-Medical Switching Hurts Patients
Alliance for Patient Access, February 2019 - Migraine & Disability
The Headache and Migraine Policy Forum, February 2019 - The Problem with Prescribing Restrictions for Migraine Medications
The Headache Migraine Policy Forum, January 2019 - Non-Medical Switching of Neurotoxins
Alliance for Patient Access, October 2018